"Papanicolaou Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.
| Descriptor ID |
D065006
|
| MeSH Number(s) |
E01.370.225.500.384.100.422 E01.370.225.998.054.422 E04.074.422 E05.200.500.384.100.422 E05.200.998.054.422 E05.242.384.100.422
|
| Concept/Terms |
Papanicolaou Test- Papanicolaou Test
- Test, Papanicolaou
- Pap Test
- Test, Pap
- Pap Smear
- Smear, Pap
- Papanicolaou Smear
- Smear, Papanicolaou
|
Below are MeSH descriptors whose meaning is more general than "Papanicolaou Test".
Below are MeSH descriptors whose meaning is more specific than "Papanicolaou Test".
This graph shows the total number of publications written about "Papanicolaou Test" by people in this website by year, and whether "Papanicolaou Test" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 4 | 4 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papanicolaou Test" by people in Profiles.
-
Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
-
Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
-
Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system. Prev Med. 2021 04; 145:106410.
-
Screening for Cervical Cancer. Am Fam Physician. 2019 02 15; 99(4):253-254.
-
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018 08 21; 320(7):687-705.
-
Role of Race/Ethnicity, Language, and Insurance in Use of Cervical Cancer Prevention Services Among Low-Income Hispanic Women, 2009-2013. Prev Chronic Dis. 2018 02 22; 15:E25.
-
Patterns and correlates of cervical cancer screening initiation in a large integrated health care system. Am J Obstet Gynecol. 2018 04; 218(4):429.e1-429.e9.
-
Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164.
-
Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system. Contemp Clin Trials. 2018 01; 64:77-87.
-
Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records. Stat Med. 2017 Sep 30; 36(22):3583-3595.